Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2013 Oct;27(10):2086-91.
doi: 10.1038/leu.2013.208. Epub 2013 Jul 9.

The CIBMTR score predicts survival of AML patients undergoing allogeneic transplantation with active disease after a myeloablative or reduced intensity conditioning: a retrospective analysis of the Gruppo Italiano Trapianto Di Midollo Osseo

E Todisco  1 , F Ciceri, E Oldani, C Boschini, C Micò, M T Vanlint, I Donnini, F Patriarca, P E Alessandrino, F Bonifazi, W Arcese, W Barberi, P Marenco, E Terruzzi, S Cortelazzo, S Santarone, A Proia, P Corradini, E Tagliaferri, S Falcioni, G Irrera, L Dallanegra, L Castagna, A Santoro, A Camboni, N Sacchi, A Bosi, A Bacigalupo, A Rambaldi
Affiliations
Multicenter Study

The CIBMTR score predicts survival of AML patients undergoing allogeneic transplantation with active disease after a myeloablative or reduced intensity conditioning: a retrospective analysis of the Gruppo Italiano Trapianto Di Midollo Osseo

E Todisco et al. Leukemia. 2013 Oct.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
(a) Kaplan–Meier estimates of overall survival, (OS, solid line, n=523) and leukemia-free survival (LFS, dotted line, n=282). (b) Kaplan-Meier estimates of overall survival for patients receiving a myeloablative (MAC, dotted line, n=332) or a reduced-intensity (RIC, solid line, n=191) conditioning regimen. (c) Incidence of relapse in patients receiving a MAC (dotted line) or RIC (solid line) conditioning regimen. (d) Non-relapse mortality (NRM) in patients receiving a MAC (dotted line) or RIC (solid line) conditioning regimen. (e) A CIBMTR scoring system validation with overall survival according to the risk score. The hazard ratio and the overall survival for score 2 and 3 proved significantly worse than 1 and 2.
See this image and copyright information in PMC

References

    1. Greinix HT, Reiter E, Keil F, Fischer G, Lechner K, Dieckmann K, et al. Leukemia-free survival and mortality in patients with refractory or relapsed acute leukemia given marrow transplants from sibling and unrelated donors. Bone Marrow Transplant. 1998;21:673–678. - PubMed
    1. Michallet M, Thomas X, Vernant JP, Kuentz M, Socie G, Esperou-Bourdeau H, et al. Long-term outcome after allogeneic hematopoietic stem cell transplantation for advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Societe Francaise de Greffe de Moelle (SFGM) Bone Marrow Transplant. 2000;26:1157–1163. - PubMed
    1. Wong R, Shahjahan M, Wang X, Thall PF, De Lima M, Khouri I, et al. Prognostic factors for outcomes of patients with refractory or relapsed acute myelogenous leukemia or myelodysplastic syndromes undergoing allogeneic progenitor cell transplantation. Biol Blood Marrow Transplant. 2005;11:108–114. - PubMed
    1. Estey E. Treatment of refractory AML. Leukemia. 1996;10:932–936. - PubMed
    1. Craddock C, Labopin M, Pillai S, Finke J, Bunjes D, Greinix H, et al. Factors predicting outcome after unrelated donor stem cell transplantation in primary refractory acute myeloid leukaemia. Leukemia. 2011;25:808–813. - PubMed